Información:
Error:
ID
27816
Descripción
A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B Infection; ODM derived from: https://clinicaltrials.gov/show/NCT00605384
Link
https://clinicaltrials.gov/show/NCT00605384
Palabras clave
Versiones (1)
- 30/11/17 30/11/17 -
Titular de derechos de autor
See clinicaltrials.gov
Subido en
30 de noviembre de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Chronic Hepatitis B NCT00605384
Eligibility Chronic Hepatitis B NCT00605384
- StudyEvent: Eligibility
Similar models
Eligibility Chronic Hepatitis B NCT00605384
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Hepatitis B, Chronic
Item
chronic hbv infection
boolean
C0524909 (UMLS CUI [1])
Lamivudine | Lamivudine Resistance
Item
history of lamivudine (lvd) treatment, and lamivudine resistance (lvdr), receiving lvd at screening visit
boolean
C0209738 (UMLS CUI [1])
C0209738 (UMLS CUI [2,1])
C1514892 (UMLS CUI [2,2])
C0209738 (UMLS CUI [2,1])
C1514892 (UMLS CUI [2,2])
Liver function Compensated
Item
compensated liver function
boolean
C0232741 (UMLS CUI [1,1])
C0205432 (UMLS CUI [1,2])
C0205432 (UMLS CUI [1,2])
Hepatitis B DNA Measurement
Item
hbv dna ≥ 172,000 iu/ml
boolean
C3641250 (UMLS CUI [1])
Hepatitis B e antigen positive | Hepatitis B e antigen negative
Item
hepatitis b e-antigen (hbeag)-positive or hbeag-negative
boolean
C0392390 (UMLS CUI [1])
C0948827 (UMLS CUI [2])
C0948827 (UMLS CUI [2])
Decompensated cirrhosis
Item
evidence of decompensated cirrhosis
boolean
C1619727 (UMLS CUI [1])
HIV coinfection | HCV coinfection | HDV Coinfection
Item
coinfection with human immunodeficiency virus (hiv), hepatitis c virus (hcv), or hepatitis d virus (hdv)
boolean
C4062778 (UMLS CUI [1])
C1698259 (UMLS CUI [2])
C0011220 (UMLS CUI [3,1])
C0275524 (UMLS CUI [3,2])
C1698259 (UMLS CUI [2])
C0011220 (UMLS CUI [3,1])
C0275524 (UMLS CUI [3,2])
Pancreatitis
Item
recent history of pancreatitis
boolean
C0030305 (UMLS CUI [1])
serum alpha-fetoprotein measurement
Item
serum alpha fetoprotein > 100 ng/ml
boolean
C0546833 (UMLS CUI [1])
Exception Lamivudine | Nucleoside Analogs Antiviral Agents Against Hepatitis B | Nucleotide analog Antiviral Agents Against Hepatitis B
Item
except lamivudine, any prior therapy with nucleoside or nucleotide analogue antiviral agents with activity against hepatitis b
boolean
C1705847 (UMLS CUI [1,1])
C0209738 (UMLS CUI [1,2])
C1579410 (UMLS CUI [2,1])
C0003451 (UMLS CUI [2,2])
C0521124 (UMLS CUI [2,3])
C0019163 (UMLS CUI [2,4])
C0597107 (UMLS CUI [3,1])
C0003451 (UMLS CUI [3,2])
C0521124 (UMLS CUI [3,3])
C0019163 (UMLS CUI [3,4])
C0209738 (UMLS CUI [1,2])
C1579410 (UMLS CUI [2,1])
C0003451 (UMLS CUI [2,2])
C0521124 (UMLS CUI [2,3])
C0019163 (UMLS CUI [2,4])
C0597107 (UMLS CUI [3,1])
C0003451 (UMLS CUI [3,2])
C0521124 (UMLS CUI [3,3])
C0019163 (UMLS CUI [3,4])